Abstract
The management of acute disseminated intravascular coagulopathy (DIC) due to solid tumour malignancies can be challenging, as treating the underlying cause with cytotoxic chemotherapy may have limited effectiveness and significant toxicity. The advent of targeted therapies for malignancies is changing the treatment landscape. We report the successful management of a patient with a life-threatening coagulopathy due to BRAF-mutated melanoma.
| Original language | English |
|---|---|
| Pages (from-to) | 207-208 |
| Number of pages | 2 |
| Journal | Internal Medicine Journal |
| Volume | 44 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Feb 2014 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Successful management of life-threatening disseminated intravascular coagulopathy due to metastatic melanoma'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver